CPT Codes Mapped to CVX Codes
This table cross-references Current Procedural Terminology (CPT™) codes that are related to vaccines, toxoids and immune globulins with their corresponding CVX codes.
Available Printable versions:
Sort Table by Column: Simply click on the column heading to sort the table accordingly.
The Last Updated column indicates the last time this particular CPT code was updated in this table.
CPT CODE | CPT Description | CVX Code | Vaccine Name | Comments | Last Updated Date |
---|---|---|---|---|---|
90281 | Immune globulin (IG), human, for intramuscular use | 86 | IG | 5/28/2010 | |
90283 | Immune globulin (IGIV), human, for intravenous use | 87 | IGIV | 5/28/2010 | |
90287 | Botulinum antitoxin, equine, any route | 27 | botulinum antitoxin | 5/28/2010 | |
90291 | Cytomegalovirus immune globulin (CMV-IGIV), human, for intravenous use | 29 | CMVIG | 5/28/2010 | |
90296 | Diphtheria antitoxin, equine, any route | 12 | diphtheria antitoxin | 5/28/2010 | |
90371 | Hepatitis B immune globulin (HBIG), human, for intramuscular use | 30 | HBIG | 5/28/2010 | |
90375 | Rabies immune globulin (RIG), human, for intramuscular and/or subcutaneous use | 34 | RIG | 5/28/2010 | |
90376 | Rabies immune globulin, heat-treated (RIG-HT), human, for intramuscular and/or subcutaneous use | 34 | RIG | 5/28/2010 | |
90378 | Respiratory syncytial virus immune globulin (RSV-IgIM), for intramuscular use, 50 mg, each | 93 | RSV-MAb | 5/28/2010 | |
90379 | Respiratory syncytial virus immune globulin (RSV-IGIV), human, for intravenous use | 71 | RSV-IGIV | 5/28/2010 | |
90389 | Tetanus immune globulin (TIG), human, for intramuscular use | 13 | TIG | 5/28/2010 | |
90393 | Vaccinia immune globulin, human, for intramuscular use | 79 | vaccinia immune globulin | 5/28/2010 | |
90396 | Varicella-zoster immune globulin, human, for intramuscular use | 36 | VZIG | 5/28/2010 | |
90470 | H1N1 immunization administration (intramuscular, intranasal), including counseling when performed | 128 | Novel Influenza-H1N1-09, all formulations | 8/31/2010 | |
90476 | Adenovirus vaccine, type 4, live, for oral use | 54 | adenovirus, type 4 | 5/28/2010 | |
90477 | Adenovirus vaccine, type 7, live, for oral use | 55 | adenovirus, type 7 | 5/28/2010 | |
90581 | Anthrax vaccine, for subcutaneous use | 24 | anthrax | 5/28/2010 | |
90585 | Bacillus Calmette-Guerin vaccine (BCG) for tuberculosis, live, for percutaneous use | 19 | BCG | 5/28/2010 | |
90620 | Meningococcal recombinant protein and outer membrane vesicle vaccine, serogroup B, 2 dose schedule, for intramuscular | 163 | meningococcal B, OMV | 2/20/2015 | |
90621 | Meningococcal recombinant lipoprotein vaccine, serogroup B, 3 dose schedule, for intramuscular use | 162 | meningococcal B, recombinant | 11/6/2014 | |
90625 | Cholera vaccine live, adult dosage, 1 dose schedule, for oral use | 174 | cholera, live attenuated | 8/24/2016 | |
90630 | Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use | 166 | influenza, intradermal, quadrivalent, preservative free | 1/9/2015 | |
90632 | Hepatitis A vaccine, adult dosage, for intramuscular use | 52 | Hep A, adult | 5/28/2010 | |
90633 | Hepatitis A vaccine, pediatric/adolescent dosage-2 dose schedule, for intramuscular use | 83 | Hep A, ped/adol, 2 dose | 5/28/2010 | |
90634 | Hepatitis A vaccine, pediatric/adolescent dosage-3 dose schedule, for intramuscular use | 84 | Hep A, ped/adol, 3 dose | 5/28/2010 | |
90636 | Hepatitis A and hepatitis B (HepA-HepB), adult dosage, for intramuscular use | 104 | Hep A-Hep B | 5/28/2010 | |
90644 | Meningococcal conjugate vaccine, serogroups C amp; Y and Hemophilus influenza B vaccine (MenCY-Hib) | 148 | Meningococcal C/Y-HIB PRP | 1/9/2015 | |
90645 | Haemophilus influenza b vaccine (Hib), HbOC conjugate (4 dose schedule), for intramuscular use | 47 | Hib (HbOC) | 5/28/2010 | |
90646 | Haemophilus influenza b vaccine (Hib), PRP-D conjugate, for booster use only, intramuscular use | 46 | Hib (PRP-D) | 5/28/2010 | |
90647 | Haemophilus influenza b vaccine (Hib), PRP-OMP conjugate (3 dose schedule), for intramuscular use | 49 | Hib (PRP-OMP) | 5/28/2010 | |
90648 | Haemophilus influenza b vaccine (Hib), PRP-T conjugate (4 dose schedule), for intramuscular use | 48 | Hib (PRP-T) | 5/28/2010 | |
90649 | Human Papilloma virus (HPV) vaccine, types 6, 11, 16, 18 (quadrivalent) 3 dose schedule, for intramuscular use | 62 | HPV, quadrivalent | 5/28/2010 | |
90650 | Human Papilloma virus (HPV) vaccine, types 16, 18, bivalent, 3 dose schedule, for intramuscular use | 118 | HPV, bivalent | 5/28/2010 | |
90651 | Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (HPV) | 165 | HPV9 | 1/9/2015 | |
90653 | Influenza virus vaccine, inactivated, subunit, adjuvanted for IM us | 168 | influenza, trivalent, adjuvanted | 4/25/2016 | |
90654 | Influenza virus vaccine, split virus, preservative free, for intradermal use | 144 | influenza, seasonal, intradermal, preservative free | 8/1/2012 | |
90655 | Influenza virus vaccine, trivalent, split virus, preservative free, for children 6-35 months of age, for intramuscular use | 140 | Influenza, seasonal, injectable, preservative free | 4/25/2016 | |
90656 | Influenza virus vaccine, trivalent, split virus, preservative free, for use in individuals 3 years of age and above, for intramuscular use | 140 | Influenza, seasonal, injectable, preservative free | 4/25/2016 | |
90657 | Influenza virus vaccine, trivalent, split virus, for children 6-35 months of age, for intramuscular use | 141 | Influenza, seasonal, injectable | 4/25/2016 | |
90658 | Influenza virus vaccine,trivalent, split virus, for use in individuals 3 years of age and above, for intramuscular use | 141 | Influenza, seasonal, injectable | 4/25/2016 | |
90659 | Influenza virus vaccine, whole virus, for intramuscular or jet injection use | 16 | influenza, whole | 3/17/2011 | |
90660 | Influenza virus vaccine, trivalent, live, for intranasal use | 111 | influenza, live, intranasal | 4/25/2016 | |
90661 | Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use | 153 | Influenza, injectable, MDCK, preservative free | 9/5/2013 | |
90662 | Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use | 135 | Influenza, high dose seasonal | 5/28/2010 | |
90663 | Influenza virus vaccine, pandemic formulation, H1N1 | 128 | Novel Influenza-H1N1-09, all formulations | 8/31/2010 | |
90664 | Influenza virus vaccine, pandemic formulation, live, for intranasal use | 125 | Novel Influenza-H1N1-09, nasal | 8/31/2010 | |
90665 | Lyme disease vaccine, adult dosage, for intramuscular use | 66 | Lyme disease | 4/25/2016 | |
90666 | Influenza virus vaccine, pandemic formulation, split-virus, preservative free, for intramuscular use | 126 | Novel influenza-H1N1-09, preservative-free | 8/31/2010 | |
90668 | Influenza virus vaccine, pandemic formulation, split-virus, for intramuscular use | 127 | Novel influenza-H1N1-09 | 8/31/2010 | |
90669 | Pneumococcal conjugate vaccine, polyvalent, for children under five years, for intramuscular use | 100 | pneumococcal conjugate PCV 7 | 5/28/2010 | |
90670 | Pneumococcal conjugate vaccine, 13 valent, for intramuscular use | 133 | Pneumococcal conjugate PCV 13 | 5/28/2010 | |
90672 | Influenza virus vaccine, quadrivalent (LAIV), live, intranasal use | 149 | influenza, live, intranasal, quadrivalent | 4/25/2016 | |
90673 | Influenza virus vaccine, trivalent, derived from recombinant DNA (RIV3), hemagglutnin (HA) protein only, preservative and antibiotic free, for intramuscular use | 155 | influenza, recombinant, injectable, preservative free | 8/21/2013 | |
90674 | Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use | 171 | Influenza, injectable, MDCK, preservative free, quadrivalent | 6/29/2016 | |
90675 | Rabies vaccine, for intramuscular use | 175 | Rabies - IM Diploid cell culture | 11/22/2016 | |
90675 | Rabies vaccine, for intramuscular use | 176 | Rabies - IM fibroblast culture | 11/22/2016 | |
90675 | Rabies vaccine, for intramuscular use | 18 | rabies, intramuscular injection | 5/28/2010 | |
90676 | Rabies vaccine, for intradermal use | 40 | rabies, intradermal injection | 5/28/2010 | |
90680 | Rotavirus vaccine, pentavalent, 3 dose schedule, live, for oral use | 116 | rotavirus, pentavalent | 5/28/2010 | |
90681 | Rotavirus vaccine, human, attenuated, 2 dose schedule, live, for oral use | 119 | rotavirus, monovalent | 5/28/2010 | |
90685 | Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular us | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | 8/11/2014 | |
90686 | Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use | 150 | influenza, injectable, quadrivalent, preservative free | 1/3/2013 | |
90687 | Influenza virus vaccine, quadrivalent, split virus, when administered to children 6-35 months of age, for intramuscular use | 158 | influenza, injectable, quadrivalent | 6/11/2014 | |
90688 | Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use | 158 | influenza, injectable, quadrivalent | 1/3/2013 | |
90690 | Typhoid vaccine, live, oral | 25 | typhoid, oral | 5/28/2010 | |
90691 | Typhoid vaccine, Vi capsular polysaccharide (ViCPs), for intramuscular use | 101 | typhoid, ViCPs | 5/28/2010 | |
90692 | Typhoid vaccine, heat- and phenol-inactivated (H-P), for subcutaneous or intradermal use | 41 | typhoid, parenteral | 5/28/2010 | |
90693 | Typhoid vaccine, acetone-killed, dried (AKD), for subcutaneous use (U.S. military) | 53 | typhoid, parenteral, AKD (U.S. military) | 5/28/2010 | |
90696 | Diphtheria, tetanus toxoids, acellular pertussis vaccine and poliovirus vaccine, inactivated (DTaP-IPV), when administered to children 4 years through 6 years of age, for intramuscular use | 130 | DTaP-IPV | 5/28/2010 | |
90697 | Diphtheria, tetanus toxoids, acellular pertussis vaccine, inactivated poliovirus vaccine, Haemophilus influenzae type b PRP-OMP conjugate vaccine, and hepatitis B vaccine (DTaP-IPV-Hib-HepB), for intramuscular use | 146 | DTaP,IPV,Hib,HepB | 8/24/2016 | |
90698 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine, haemophilus influenza Type B, and poliovirus vaccine, inactivated (DTaP - Hib - IPV), for intramuscular use | 120 | DTaP-Hib-IPV | 5/28/2010 | |
90700 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use | 106 | DTaP, 5 pertussis antigens | 9/28/2010 | |
90700 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine (DTaP), for use in individuals younger than seven years, for intramuscular use | 20 | DTaP | 5/28/2010 | |
90701 | Diphtheria, tetanus toxoids, and whole cell pertussis vaccine (DTP), for intramuscular use | 01 | DTP | 4/25/2016 | |
90702 | Diphtheria and tetanus toxoids (DT) adsorbed for use in individuals younger than seven years, for intramuscular use | 28 | DT (pediatric) | 5/28/2010 | |
90703 | Tetanus toxoid adsorbed, for intramuscular use | 35 | tetanus toxoid, adsorbed | 5/28/2010 | |
90704 | Mumps virus vaccine, live, for subcutaneous use | 07 | mumps | 5/28/2010 | |
90705 | Measles virus vaccine, live, for subcutaneous use | 05 | measles | 5/28/2010 | |
90706 | Rubella virus vaccine, live, for subcutaneous use | 06 | rubella | 5/28/2010 | |
90707 | Measles, mumps and rubella virus vaccine (MMR), live, for subcutaneous use | 03 | MMR | 5/28/2010 | |
90708 | Measles and rubella virus vaccine, live, for subcutaneous use | 04 | M/R | 5/28/2010 | |
90710 | Measles, mumps, rubella, and varicella vaccine (MMRV), live, for subcutaneous use | 94 | MMRV | 5/28/2010 | |
90712 | Poliovirus vaccine, (any type(s)) (OPV), live, for oral use | 02 | OPV | 5/28/2010 | |
90713 | Poliovirus vaccine, inactivated, (IPV), for subcutaneous or intramuscular use | 10 | IPV | 5/28/2010 | |
90714 | Tetanus and Diphtheria, adsorbed | 09 | Td (adult), adsorbed | 12/12/2016 | |
90714 | Typhoid vaccine | 91 | typhoid, unspecified formulation | This cpt code has been reused for TD, preservative free. | 3/17/2011 |
90714 | Tetanus and diphtheria toxoids (Td) adsorbed, preservative free, for use in individuals seven years or older, for intramuscular use | 113 | Td (adult) preservative free | Beginning in 2005, this CPT code maps to TD preservative free. | 5/28/2010 |
90715 | Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), for use in individuals 7 years or older, for intramuscular use | 115 | Tdap | 5/28/2010 | |
90716 | Varicella virus vaccine, live, for subcutaneous use | 21 | varicella | 5/28/2010 | |
90717 | Yellow fever vaccine, live, for subcutaneous use | 37 | yellow fever | 5/28/2010 | |
90718 | Tetanus and diphtheria toxoids (Td) adsorbed for use in individuals seven years or older, for intramuscular use | 09 | Td (adult), adsorbed | 5/28/2010 | |
90720 | Diphtheria, tetanus toxoids, and whole cell pertussis vaccine and Hemophilus influenza B vaccine (DTP-Hib), for intramuscular use | 22 | DTP-Hib | 5/28/2010 | |
90721 | Diphtheria, tetanus toxoids, and acellular pertussis vaccine and Hemophilus influenza B vaccine (DTaP-Hib), for intramuscular use | 50 | DTaP-Hib | 5/28/2010 | |
90723 | Diphtheria, tetanus toxoids, acellular pertussis vaccine, Hepatitis B, and poliovirus vaccine, inactivated (DTaP-HepB-IPV), for intramuscular use | 110 | DTaP-Hep B-IPV | 5/28/2010 | |
90724 | Influenza virus vaccine | 88 | influenza, unspecified formulation | 3/17/2011 | |
90725 | Cholera vaccine for injectable use | 26 | cholera, unspecified formulation | 5/28/2010 | |
90726 | Rabies vaccine | 90 | rabies, unspecified formulation | 3/17/2011 | |
90727 | Plague vaccine, for intramuscular use | 23 | plague | 5/28/2010 | |
90728 | BCG vaccine | 19 | BCG | 3/17/2011 | |
90730 | Hepatitis A vaccine | 85 | Hep A, unspecified formulation | 3/17/2011 | |
90731 | Hepatitis B vaccine | 45 | Hep B, unspecified formulation | 3/17/2011 | |
90732 | Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use | 33 | pneumococcal polysaccharide PPV23 | 5/28/2010 | |
90733 | Meningococcal polysaccharide vaccine (any group(s)), for subcutaneous use | 32 | meningococcal MPSV4 | 5/28/2010 | |
90734 | Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use | 114 | meningococcal MCV4P | This CPT maps to 2 vaccines (MCV4P and MCV4O) | 5/28/2010 |
90734 | Meningococcal conjugate vaccine, serogroups A, C, Y and W-135 (tetravalent), for intramuscular use | 136 | Meningococcal MCV4O | This CPT maps to 2 vaccines (MCV4P and MCV4O) | 5/28/2010 |
90735 | Japanese encephalitis virus vaccine, for subcutaneous use | 39 | Japanese encephalitis SC | 5/28/2010 | |
90736 | Zoster (shingles) vaccine, live, for subcutaneous injection | 121 | zoster | 5/28/2010 | |
90737 | Hemophilus influenza B | 17 | Hib, unspecified formulation | 3/17/2011 | |
90738 | Japanese encephalitis virus vaccine, inactivated, for intramuscular use | 134 | Japanese Encephalitis IM | 5/28/2010 | |
90739 | Hepatitis B, adult dosage (2 dose schedule), for intramuscular use | 43 | Hep B, adult | 4/25/2016 | |
90740 | Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3 dose schedule), for intramuscular use | 44 | Hep B, dialysis | 5/28/2010 | |
90741 | Immunization, passive; immune serum globulin, human (ISG) | 14 | IG, unspecified formulation | 3/17/2011 | |
90743 | Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular use | 43 | Hep B, adult | 5/28/2010 | |
90744 | Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule), for intramuscular use | 08 | Hep B, adolescent or pediatric | 5/28/2010 | |
90745 | Hepatitis B vaccine, adolescent/high risk infant dosage, for intramuscular use | 42 | Hep B, adolescent/high risk infant | 3/17/2011 | |
90746 | Hepatitis B vaccine, adult dosage, for intramuscular use | 43 | Hep B, adult | 5/28/2010 | |
90747 | Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4 dose schedule), for intramuscular use | 44 | Hep B, dialysis | 5/28/2010 | |
90748 | Hepatitis B and Hemophilus influenza b vaccine (HepB-Hib), for intramuscular use | 51 | Hib-Hep B | 5/28/2010 |
CPT codes are developed and maintained by the American Medical Association and are intended to support billing for services. CPT codes have been reproduced here with permission from the American Medical Association (AMA). CPT five-digit codes, nomenclature and other data are Copyright, American Medical Association. All Rights Reserved. No fee schedules, basic units, relative values or related listings are included in this cross-reference. The AMA assumes no liability for the data contained herein. Applicable FARS/DFARS restrictions apply to government use.
CVX codes are codes that indicate the product used in a vaccination. They are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.
The goal of the table is to support mapping of CPT codes to CVX codes. It is not intended to support mapping from CVX to CPT nor to be a definitive source for CPT codes. Active CPT codes, inactive CPT codes and pre-release CPT codes are included. Every effort is made to keep the codes current.
Questions regarding this table should be directed to the IIS Technical Assistance Team; CDC, National Centers for Immunization and Respiratory Diseases, Immunization Information Systems Support Branch-Informatics, 1600 Clifton Road, Mailstop E-62, Atlanta, GA 30333.
For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:
CDC, National Centers for Immunization and Respiratory DiseasesEmail:
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333
iisinfo@cdc.gov (note change)
- Page last reviewed:November 9, 2016
- Page last updated:December 14, 2016
- Content source: